Portage Biotech Inc Asset Resilience Ratio

Latest as of March 2021: 0.00%

Portage Biotech Inc asset resilience ratio. Portage Biotech Inc (PRTG) has an Asset Resilience Ratio of 0.00% as of March 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See PRTG defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$0.00

Cash + Short-term Investments

Total Assets

$174.86 Million

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Portage Biotech Inc (2000–2021)

Asset resilience ratio of Portage Biotech Inc from 2000 to 2021. This chart shows how Portage Biotech Inc's Asset Resilience Ratio has changed over time. Read Portage Biotech Inc (PRTG) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Portage Biotech Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see PRTG total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$0.00	0%
Total Liquid Assets	$0.00	0.00%

Asset Resilience Insights

Limited Liquidity: Portage Biotech Inc maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company maintains a balanced mix of cash and short-term investments.

Portage Biotech Inc Industry Peers by Asset Resilience Ratio

Compare Portage Biotech Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	21.11%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Chengdu Easton Biopharmaceuticals Co Ltd SHG:688513	Biotechnology	35.16%
China Resources Boya Bio pharmaceutical Group Co Ltd SHE:300294	Biotechnology	23.15%
Wuhan Keqian Biology Co Ltd SHG:688526	Biotechnology	19.42%
Achieve Life Sciences Inc F:SP4P	Biotechnology	3.60%

Portage Biotech Inc Asset Resilience Ratio by Year (2000–2021)

Portage Biotech Inc asset resilience ratio by year from 2000 to 2021. The table below shows the annual Asset Resilience Ratio data for Portage Biotech Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2021-03-31	0.00%	$0.00	$174.86 Million	--
2020-03-31	0.04%	$68.00K	$173.17 Million	-0.02pp
2019-03-31	0.06%	$103.00K	$173.72 Million	-0.46pp
2018-03-31	0.52%	$52.00K	$10.00 Million	-97.83pp
2017-03-31	98.35%	$58.91 Million	$59.90 Million	+95.31pp
2012-03-31	3.04%	$228.12K	$7.51 Million	-17.29pp
2011-03-31	20.32%	$1.96 Million	$9.62 Million	+7.27pp
2010-03-31	13.05%	$1.33 Million	$10.22 Million	-55.48pp
2009-03-31	68.52%	$864.47K	$1.26 Million	-0.83pp
2008-03-31	69.36%	$3.53 Million	$5.09 Million	+19.67pp
2007-03-31	49.69%	$2.87 Million	$5.78 Million	+17.07pp
2006-03-31	32.62%	$1.53 Million	$4.68 Million	+31.11pp
2005-03-31	1.51%	$63.15K	$4.20 Million	-25.91pp
2000-03-31	27.42%	$480.04K	$1.75 Million	--

pp = percentage points

About Portage Biotech Inc

NASDAQ:PRTG USA Biotechnology

Market Cap

$10.71 Million

Market Cap Rank

#26748 Global

#5574 in USA

Share Price

$4.70

Change (1 day)

-0.84%

52-Week Range

$4.70 - $4.74

All Time High

$1236.00